ASLN vs. SXTP, ATNF, ALZN, NCNA, CMND, APM, PWUP, KLTO, CANF, and ADIL
Should you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include 60 Degrees Pharmaceuticals (SXTP), 180 Life Sciences (ATNF), Alzamend Neuro (ALZN), NuCana (NCNA), Clearmind Medicine (CMND), Aptorum Group (APM), PowerUp Acquisition (PWUP), Klotho Neurosciences (KLTO), Can-Fite BioPharma (CANF), and Adial Pharmaceuticals (ADIL). These companies are all part of the "pharmaceutical products" industry.
ASLAN Pharmaceuticals vs.
ASLAN Pharmaceuticals (NASDAQ:ASLN) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking.
60 Degrees Pharmaceuticals' return on equity of 0.00% beat ASLAN Pharmaceuticals' return on equity.
60 Degrees Pharmaceuticals has lower revenue, but higher earnings than ASLAN Pharmaceuticals. 60 Degrees Pharmaceuticals is trading at a lower price-to-earnings ratio than ASLAN Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
58.8% of ASLAN Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.0% of 60 Degrees Pharmaceuticals shares are owned by institutional investors. 4.7% of ASLAN Pharmaceuticals shares are owned by company insiders. Comparatively, 10.3% of 60 Degrees Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, 60 Degrees Pharmaceuticals had 4 more articles in the media than ASLAN Pharmaceuticals. MarketBeat recorded 4 mentions for 60 Degrees Pharmaceuticals and 0 mentions for ASLAN Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 0.22 beat ASLAN Pharmaceuticals' score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.
ASLAN Pharmaceuticals received 199 more outperform votes than 60 Degrees Pharmaceuticals when rated by MarketBeat users. Likewise, 63.49% of users gave ASLAN Pharmaceuticals an outperform vote while only 5.00% of users gave 60 Degrees Pharmaceuticals an outperform vote.
ASLAN Pharmaceuticals presently has a consensus target price of $72.00, suggesting a potential upside of 11,900.00%. Given ASLAN Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts clearly believe ASLAN Pharmaceuticals is more favorable than 60 Degrees Pharmaceuticals.
ASLAN Pharmaceuticals has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Comparatively, 60 Degrees Pharmaceuticals has a beta of 3.41, indicating that its share price is 241% more volatile than the S&P 500.
Summary
ASLAN Pharmaceuticals beats 60 Degrees Pharmaceuticals on 9 of the 17 factors compared between the two stocks.
Get ASLAN Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ASLAN Pharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:ASLN) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy ASLN Stock Free ASLN Stock Alerts